Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-100,000
Closed -$2.88M 64
2023
Q4
$2.88M Sell
100,000
-150,000
-60% -$4.53M 0.36% 33
2023
Q3
$8.29M Buy
+250,000
New +$8.84M 0.37% 20
2016
Q2
Sell
-1,400,239
Closed -$39.4M 42
2016
Q1
$39.4M Buy
+1,400,239
New +$40M 1.86% 21

Other funds holding PFE

TIG Advisors LLC's PFE Position: Q4 2023 in Review

TIG Advisors LLC sold out of Pfizer (PFE) in Q4 2023, closing a stake of 183,397 shares — an estimated $5.54M sold.

TIG Advisors LLC first reported a position in PFE in Q1 2016 and held it in 2 quarters. The position peaked at $6.08M in Q3 2023. 2,935 funds tracked by Wall St. Rank hold PFE as of Q4 2023.

  • TIG Advisors LLC reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
  • TIG Advisors LLC sold 183,397 Pfizer shares in Q4 2023, an estimated $5.54M.
  • TIG Advisors LLC first reported a position in Pfizer in Q1 2016 and held it in 2 quarters.
  • TIG Advisors LLC's Pfizer position peaked at $6.08M in Q3 2023.
  • 2,935 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.

Based on TIG Advisors LLC's 13F filing for Q4 2023, filed 14 Feb 2024.